Shaping the future of medicine with powerful therapeutic and diagnostic platforms

Therapeutics

Novel cancer therapies combining Affimer® biotherapeutics and pre|CISION™ tumour microenvironment activation >

Diagnostics

M&A led growth with a vision to build a European IVD business with global reach >

Investors

Growing shareholder value by developing novel cancer therapies and powerful diagnostics using our proprietary Affimer® and pre|CISION™ platforms. >

NOW IN CLINIC

AVA6000, tumour microenvironment activated chemotherapy, powered by the pre|CISIONTM platform.

Read more